Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma

Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic effect of a medication, play critical roles in the drug’s delivery, stability, and patient acceptability. The decision to switch excipients can be driven by various […] Source